| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |